NLRP3-mediated pyroptosis exhibited an elevation in the livers of both ob/ob and diabetic mice, and inhibiting NLRP3 in the liver protected against the progression of NAFLD (82). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.